Clinical trials
Inflammatory Bowel Diseases trials in Israel
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
67 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2006 | 1 |
| 2007 | 2 |
| 2008 | 2 |
| 2009 | 2 |
| 2010 | 3 |
| 2011 | 6 |
| 2012 | 5 |
| 2013 | 2 |
| 2014 | 2 |
| 2015 | 3 |
| 2016 | 6 |
| 2017 | 6 |
| 2018 | 5 |
| 2019 | 2 |
| 2020 | 3 |
| 2021 | 3 |
| 2022 | 2 |
| 2023 | 3 |
| 2024 | 3 |
| 2025 | 4 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 28 |
| Unknown status | 14 |
| Terminated | 11 |
| Recruiting | 7 |
| Active, not recruiting | 4 |
| Not yet recruiting | 2 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Tel-Aviv Sourasky Medical Center | 8 |
| Eli Lilly and Company | 5 |
| Janssen Research & Development, LLC | 5 |
| Shaare Zedek Medical Center | 5 |
| Meir Medical Center | 4 |
| AbbVie | 3 |
| Medtronic - MITG | 3 |
| Schneider Children's Medical Center, Israel | 3 |
| Sheba Medical Center | 3 |
| Shmuel Kivity, MD | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Inflammatory Bowel Diseases | 67 |
| Crohn Disease | 29 |
| Colitis, Ulcerative | 22 |
| Colitis | 5 |
| Gastrointestinal Diseases | 3 |
| Inflammation | 2 |
| Arthritis, Rheumatoid | 1 |
| Cholangitis, Sclerosing | 1 |
| Chronobiology Disorders | 1 |
| Fatty Liver | 1 |
Trials
Showing 1 to 25 of 67. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.